133 related articles for article (PubMed ID: 2140663)
1. Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms.
Erkkola R; Hirvonen E; Luikku J; Lumme R; Männikkö H; Aydinlik S
Acta Obstet Gynecol Scand; 1990; 69(1):61-5. PubMed ID: 2140663
[TBL] [Abstract][Full Text] [Related]
2. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
3. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
Gollnick H; Albring M; Brill K
Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
Porcile A; Gallardo E
Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Vartiainen M; de Gezelle H; Broekmeulen CJ
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
[TBL] [Abstract][Full Text] [Related]
7. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
8. [Clinical use of antiandrogens in the female].
Moltz L; Schwartz U; Hammerstein J
Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
[TBL] [Abstract][Full Text] [Related]
9. Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
Jandrain BJ; Humblet DM; Jaminet CB; Scheen AJ; Gaspard UJ; Lefebvre PJ
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):378-81. PubMed ID: 2142578
[TBL] [Abstract][Full Text] [Related]
10. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study].
Moltz L; Kaiser E
Geburtshilfe Frauenheilkd; 1984 Jan; 44(1):47-52. PubMed ID: 6230282
[TBL] [Abstract][Full Text] [Related]
11. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
12. Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Cea Soriano L; Asiimwe A; García Rodriguez LA
Contraception; 2017 Mar; 95(3):299-305. PubMed ID: 27769766
[TBL] [Abstract][Full Text] [Related]
13. The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen.
Lachnit-Fixson U
Acta Obstet Gynecol Scand Suppl; 1979; 88():33-42. PubMed ID: 160741
[TBL] [Abstract][Full Text] [Related]
14. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Bitzer J; Römer T; Lopes da Silva Filho A
Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):172-182. PubMed ID: 28447864
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
[TBL] [Abstract][Full Text] [Related]
16. [Management of virilization with an antiandrogen-containing contraceptive].
Apró G; Sas M
Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
[TBL] [Abstract][Full Text] [Related]
17. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
van Wayjen RG; van den Ende A
Exp Clin Endocrinol Diabetes; 1995; 103(4):241-51. PubMed ID: 7584530
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Jung-Hoffmann C; Fitzner M; Kuhl H
Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
[TBL] [Abstract][Full Text] [Related]
19. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Seaman HE; de Vries CS; Farmer RD
Hum Reprod; 2003 Mar; 18(3):522-6. PubMed ID: 12615818
[TBL] [Abstract][Full Text] [Related]
20. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
Venturoli S; Porcu E; Gammi L; Fabbri R; Paradisi R; Flamigni C; Patrono D; Capelli M; Paoletti C
Acta Eur Fertil; 1988; 19(3):129-34. PubMed ID: 2976224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]